Article Text

Download PDFPDF
P156 The development of an interstitial lung disease (ILD) electronic dashboard to drive quality improvement
  1. SL Barratt1,
  2. D Pratt1,
  3. A Chung2,
  4. C Ridley2,
  5. B Hewlett2,
  6. L Towers2,
  7. A Edey1,
  8. H Gunawardena1,
  9. H Adamali1
  1. 1Bristol Interstitial Lung Disease service, North Bristol NHS Trust, Bristol, UK
  2. 2North Bristol NHS Trust, Bristol, UK

Abstract

Introduction Dashboards are considered an effective way to monitor key performance indicators (KPIs) in management practice. Publicly available NICE quality standards for the management of Idiopathic Pulmonary Fibrosis (IPF) and statutory requirements to submit quarterly specialised service quality dashboard information (SSQD) for commissioned ILD centres is driving the need to have readily available data on KPIs of service delivery. Our objective was to develop an electronic dashboard to capture ILD activity using recognised ‘model for improvement’ frameworks.

Methods In conjunction with our business intelligence department we undertook a quality improvement project (QIP) using data stored in our ILD MDT database and patient administration system (Lorenzo), to develop an electronic ILD dashboard. The eMeasures were: 1) capture of outpatient ILD activity (something poorly assessed by HES data) 2) ILD population demographics 3) NICE quality standards for IPF and 4) the SSQD ’metric definition set’.

Prototype electronic queries were built using numerator and denominator populations of ILD patients using standardised, ICD-10 coded terminology (inpatients) and named ILD clinics (outpatients) to enable automatic extraction of data.

We adjusted clinical workflows, documentation and electronic queries through Plan-Do-Study-Act cycles to enable standardised information collection.

Results The dashboard was conceptualised in June 2017, producing monthly reports to all our stakeholders. Between July 2017 to June 2018, 1200 patients were reviewed in outpatients. For the month of June 2018, 27 new(N) and 118 follow-up(F-up) ILD appointments were undertaken (N:F-up ratio of 1:4.4). The ‘did not attend’ rate was 3.3%.

With regards to the NICE quality standards for IPF, data from the last quarter suggests that 100% ILD patients were discussed in our MDT, with 82.4% patients receiving lung function within 3 months of assessment. 90% of IPF patients had lung function testing on an annual basis. Emergency admission rate for respiratory deterioration of IPF patients was 2.2%, with an annual ILD mortality rate of 6.2%.

Conclusion The development of an electronic dashboard has increased the accessibility of useful data to understand service quality and delivery. It enables us to fulfil statutory requirements for SSQD submission easily, providing a platform for future benchmarking of QIPs in service delivery.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.